Medical and Pharmaceutical bioAffinity Technologies obtains Canadian patent for lung cancer spit test The CyPath Lung screening tool is also patented in China, Australia and Japan Rowan Dunne23 hours ago
Medical and Pharmaceutical bioAffinity Technologies secures Australian patent for ‘CyPath Lung’ spit test It will be issued within 3 months provided that there are no opposition filings made by third parties Rowan DunneJanuary 22, 2025